Find verified Brotizolam API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Brotizolam for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Brotizolam API.
Alternate Names: Lendormin, Mederantil, Sintonal, Nimbisan
CAS No: 57801-81-7
PubChem CID: 2451
Mol Formula: C15H10BrClN4S
Mol Weight: 393.7 g/mol
Controlled Drug Substance: Yes (Schedule IV)
IUPAC Name: 4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene
Therapeutic use: Sleeping drugs
Drug Class: Benzodiazepines
Commercial / Development Status: Commercial APIs
Source / Manufacturing Origin: Synthetic APIs
API Description: Brotizolam is a sedative-hypnotic thienodiazepine drug which is a benzodiazepine analog. It demonstrates anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant effects. Brotizolam has similar effects to short-acting benzodiazepines such as triazolam. Brotizolam is indicated for 2-4 weeks of treatment for severe or debilitating insomnia. Brotizolam is an extremely potent drug and it is rapidly eliminated with an average half-life of 4.4 hours (range 3.6 - 7.9 hours). Brotizolam is not approved for sale in the UK, United States or Canada but is sold in the Netherlands, Germany, Spain, Belgium, Austria, Portugal, Israel, Italy and Japan.
